par 545 (Ranitidine 300 mg)
Pill imprint par 545 has been identified as Ranitidine hydrochloride 300 mg.
Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; duodenal ulcer; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for par 545
- 300 mg
- 14.00 mm
- Elliptical / Oval
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- FD&C Yellow No. 6
pregelatinized corn starch
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|62584-0253||Amerisource Health Services|
|54868-4350||Physicians Total Care Inc (repackager)|
|49999-0428||Lake Erie Medical and Surgical Supply (repackager)|
|68115-0404||Dispensexpress Inc (repackager)|
|63874-0428||Altura Pharmaceuticals Inc (repackager)|
|66267-0452||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about ranitidine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.